Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IB Melanoma”

135 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 135 results

Testing effectiveness (Phase 2)Looking for participantsNCT06214156
What this trial is testing

A Clinical Study of T3011 in Subjects With Advanced Melanoma

Who this might be right for
Advanced Melanoma
Shanghai Pharmaceuticals Holding Co., Ltd 42
Early research (Phase 1)Active Not RecruitingNCT03025256
What this trial is testing

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

Who this might be right for
Acral Lentiginous MelanomaCentral Nervous System MelanomaClinical Stage IV Cutaneous Melanoma AJCC v8+7 more
M.D. Anderson Cancer Center 75
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Large-scale testing (Phase 3)WithdrawnNCT01826864
What this trial is testing

Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma

Who this might be right for
Stage IB MelanomaStage IIA MelanomaStage IIB Melanoma+1 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05983237
What this trial is testing

Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma

Who this might be right for
Melanoma
Jun Guo 50
Early research (Phase 1)Study completedNCT00375245
What this trial is testing

Rapamycin With Grapefruit Juice for Advanced Malignancies

Who this might be right for
TumorsNeoplasm Metastasis
University of Chicago 41
Early research (Phase 1)Active Not RecruitingNCT03929029
What this trial is testing

Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced Melanoma

Who this might be right for
Cutaneous Melanoma
Dana-Farber Cancer Institute 11
Early research (Phase 1)Not Yet RecruitingNCT07107178
What this trial is testing

A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma

Who this might be right for
Advanced MelanomaAdvanced Solid Tumor
Biotroy Therapeutics 58
Early research (Phase 1)Active Not RecruitingNCT05176470
What this trial is testing

Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients

Who this might be right for
Locally Advanced MelanomaPathologic Stage IIIB Cutaneous Melanoma AJCC v8Pathologic Stage IIIC Cutaneous Melanoma AJCC v8+2 more
Richard Wu 2
Very early researchLooking for participantsNCT07586904
What this trial is testing

Efficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon α1b in Stage III/IV Melanoma.

Who this might be right for
Melanoma (Skin Cancer)
Xijing Hospital 10
Testing effectiveness (Phase 2)Study completedNCT02807844
What this trial is testing

Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies

Who this might be right for
Triple Negative Breast CancerPancreatic CarcinomaMelanoma+1 more
Novartis Pharmaceuticals 141
Early research (Phase 1)Study completedNCT04109456
What this trial is testing

IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
InxMed (Shanghai) Co., Ltd. 51
Early research (Phase 1)Study completedNCT01656642
What this trial is testing

A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Genentech, Inc. 67
Early research (Phase 1)Study completedNCT00809588
What this trial is testing

Vaccination With Autologous, Lethally Irradiated Melanoma Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Stimulating Factor (GMSF)

Who this might be right for
Melanoma
Dana-Farber Cancer Institute 84
Testing effectiveness (Phase 2)Ended earlyNCT05714553
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Who this might be right for
Advanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more
NuCana plc 19
Early research (Phase 1)UnknownNCT03068624
What this trial is testing

Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma

Who this might be right for
Metastatic Malignant Neoplasm in the LiverMetastatic Uveal Melanoma
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Looking for participantsNCT07099430
What this trial is testing

A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma

Who this might be right for
Advanced Melanoma
Nanjing Leads Biolabs Co.,Ltd 200
Early research (Phase 1)Study completedNCT01673737
What this trial is testing

A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer

Who this might be right for
Neoplasm Malignant
Sanofi 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT03611868
What this trial is testing

APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

Who this might be right for
Unresectable or Metastatic Melanoma or Advanced Solid TumorsMelanomaUveal Melanoma+5 more
Ascentage Pharma Group Inc. 230
Testing effectiveness (Phase 2)Looking for participantsNCT05251389
What this trial is testing

FMT to Convert Response to Immunotherapy

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
The Netherlands Cancer Institute 24
Next Page